M. Dong

发表

hERG1 is involved in the pathophysiological process and inhibited by berberine in SKOV3 cells

Juan Zhang, Dahai Yu, Duo Zhi, 2019, Oncology letters.

Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis.

P. Nambiar, G. Belinsky, C. Giardina, 2003, Carcinogenesis.

The type III TGF-beta receptor suppresses breast cancer progression.

J. Marks, B. Moeller, G. Blobe, 2007, The Journal of clinical investigation.

Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies.

Ya-jun Liu, M. Dong, Si-jin Liu, 2004, World journal of gastroenterology.

New Strategies for Advanced Neuroendocrine Tumors in the Era of Targeted Therapy

James C Yao, A. Phan, James C. Yao, 2012, Clinical Cancer Research.

mTOR inhibition, a potential novel approach for bronchial carcinoids.

James C Yao, James C. Yao, M. Dong, 2011, Endocrine-related cancer.

Expression of the T Cell Receptor Vβ Repertoire in a Human T Cell Resistant to Asbestos-Induced Apoptosis and Peripheral Blood T Cells from Patients with Silica and Asbestos-Related Diseases

T. Nakano, K. Fukuoka, K. Kuribayashi, 2006, International journal of immunopathology and pharmacology.

miR-493 inhibits proliferation and invasion in pancreatic cancer cells and inversely regulated hERG1 expression

Xin Zhao, Duo Zhi, M. Dong, 2017, Oncology letters.

Cytoplasmic Phospholipase A2 Levels Correlate with Apoptosis in Human Colon Tumorigenesis

C. Giardina, D. Rosenberg, M. Nakanishi, 2005, Clinical Cancer Research.

Src-signaling interference impairs the dissemination of blood-borne tumor cells

W. Shi, D. Siemann, M. Dong, 2012, Cell and Tissue Research.

Impact of the Src inhibitor saracatinib on the metastatic phenotype of a fibrosarcoma (KHT) tumor model.

D. Siemann, Sharon Lepler, M. Dong, 2010, Anticancer research.

The role of emodin on cisplatin resistance reversal of lung adenocarcinoma A549/DDP cell

Yuan-qi Shi, Yue Xing, Shuang Liu, 2021, Anti-cancer drugs.

Genetic signatures of High- and Low-Risk Aberrant Crypt Foci in a Mouse Model of Sporadic Colon Cancer

Xiao-Jun Ma, E. Cheung, L. Achenie, 2004, Cancer Research.

Defective processing of the transforming growth factor‐β1 in azoxymethane‐induced mouse colon tumors

P. Nambiar, K. Claffey, D. Rosenberg, 2003, Molecular carcinogenesis.

Multistage gene expression profiling in a differentially susceptible mouse colon cancer model.

L. Achenie, P. Nambiar, D. Rosenberg, 2003, Cancer letters.

PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

G. Mills, K. Do, A. Rashid, 2012, Clinical Cancer Research.

Suppression of kinesin expression disrupts adenomatous polyposis coli (APC) localization and affects beta-catenin turnover in young adult mouse colon (YAMC) epithelial cells.

D. Rosenberg, H. Cui, M. Dong, 2002, Experimental cell research.

Role of transforming growth factor-beta in hematologic malignancies.

G. Blobe, M. Dong, 2006, Blood.

Long non-coding RNA NEAT1 regulates E2F3 expression by competitively binding to miR-377 in non-small cell lung cancer.

M. Dong, Junsheng Zhang, Yongli Li, 2017, Oncology letters.

Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta.

C. Wood, J. Copland, G. Blobe, 2008, Carcinogenesis.

Expression of the type III TGF- b receptor is negatively regulated by TGF- b

C. Wood, J. Copland, G. Blobe, 2008 .

The type III TGF-β receptor suppresses breast cancer progression

B. Moeller, G. Blobe, N. Hempel, 2007 .

TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity.

G. Blobe, T. Fields, R. Turley, 2008, Carcinogenesis.

The TGF-β signaling pathway has a complex role in regulating mammary carcinogenesis

B. Moeller, G. Blobe, N. Hempel, 2006 .

Azoxymethane-induced pre-adipocyte factor 1 (Pref-1) functions as a differentiation inhibitor in colonic epithelial cells.

P. Nambiar, C. Giardina, D. Rosenberg, 2004, Carcinogenesis.

Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.

Q. S. Wang, A. Papanikolaou, D. Rosenberg, 2000, International journal of oncology.

MicroRNA-148b Acts as a Tumor Suppressor in Cervical Cancer by Inducing G1/S-Phase Cell Cycle Arrest and Apoptosis in a Caspase-3-Dependent Manner

Jin Xu, M. Dong, Xiangting Xu, 2016, Medical science monitor : international medical journal of experimental and clinical research.

miR-191 Modulates Malignant Transformation of Endometriosis Through Regulating TIMP3

F. Hua, M. Dong, P. Yang, 2015, Medical science monitor : international medical journal of experimental and clinical research.

Loss of betaglycan expression in ovarian cancer: role in motility and invasion.

S. Murphy, G. Blobe, T. Fields, 2007, Cancer research.

Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.

G. Blobe, T. Fields, K. Gordon, 2008, Carcinogenesis.

XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.

Yuan-qi Shi, Shuang Liu, Shu-ya Wang, 2019, Oncology reports.

Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.

G. Blobe, T. Fields, K. Gordon, 2008, Carcinogenesis.